Literature DB >> 27446976

3H-Penciclovir (3H-PCV) Uptake Assay.

Thillai V Sekar1, Ramasamy Paulmurugan1.   

Abstract

Thymidine Kinase from human Herpes simplex virus type 1 (HSV1-TK) in combination with specific substrate prodrug nucleotide analogue ganciclovir (GCV) has been widely used as suicidal therapeutic gene for cancer gene therapy. HSV1, and its mutant (HSV1-sr39TK) with improved substrate specificity, were used as reporter genes for PET-imaging of various biological functions in small animals, by combining with radiolabeled substrates such as 18F-FHBG and 124I-FIAU. 3H-Penciclovir (PCV) uptake assay is a method of choice used to determine the expression level of HSV1-TK in mammalian cells and tissues. HSV1-TK phosphorylate PCV and result in the formation of penciclovir monophosphate, and its subsequent phopsphorylation by cellular TK lead to the formation of penciclovir triphosphate, which is trapped selectively in cells expressing HSV-TK. 3H-Penciclovir enables the detection of penciclovir uptake of mammalian cells and tissues by radioactive procedures such as scintillation counting. Here we describe the protocol to carry out 3H-Penciclovir uptakes in mammalian cells.

Entities:  

Year:  2013        PMID: 27446976      PMCID: PMC4950935          DOI: 10.21769/bioprotoc.887

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  1 in total

1.  Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.

Authors:  T V Sekar; K Foygel; J K Willmann; R Paulmurugan
Journal:  Gene Ther       Date:  2012-08-23       Impact factor: 5.250

  1 in total
  1 in total

1.  Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy.

Authors:  Elise R Robinson; Gayatri Gowrishankar; Aloma L D'Souza; Azadeh Kheirolomoom; Tom Haywood; Sharon S Hori; Hui-Yen Chuang; Yitian Zeng; Spencer K Tumbale; Amin Aalipour; Corinne Beinat; Israt S Alam; Ataya Sathirachinda; Masamitsu Kanada; Ramasamy Paulmurugan; Katherine W Ferrara; Sanjiv S Gambhir
Journal:  J Control Release       Date:  2021-05-21       Impact factor: 11.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.